Nogapendekin alfa inbakicept-PMLN: first approval milestone for BCG-unresponsive noninvasive bladder cancer: editorial.
| Autor: | Waheed A; Rawalpindi Medical College, Rawalpindi, Pakistan., Gul MH; Hayatabad Medical Complex, Peshawar, Pakistan., Wardak AB; Razia Bahlol Hospital, Afghanistan., Raja HAA; Rawalpindi Medical University, Rawalpindi, Pakistan., Hussaini H; Anaheim Regional Medical Center California, California, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 Sep 20; Vol. 86 (11), pp. 6386-6388. Date of Electronic Publication: 2024 Sep 20 (Print Publication: 2024). |
| DOI: | 10.1097/MS9.0000000000002591 |
| Abstrakt: | Competing Interests: The authors declare no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|